Navigation Links
Helix BioPharma Corp. Announces Fiscal Q1 2010 Results
Date:12/9/2009

--- --- 1,020 1,119 Expenses: Cost of sales 418 447 Research and development 2,925 1,641 Operating, general and admin 677 1,060 Sales and marketing 261 250 Amortization of capital assets 98 64 Amortization of intangible assets - 3 Stock-based compensation 160 - Interest income (14) (205) Foreign exchange loss (gain) (42) 150 --- --- 4,483 3,410 Loss before income taxes (3,463) (2,291) Income taxes 10 30 --- --- Loss for the year (3,473) (2,321) ====== ====== Loss per share: Basic (0.06) (0.05) Diluted (0.06) (0.05)



Consolidated Statements of Cash Flows
for the three month period ended October 31
(thousand $, except for per share data)
---------------------------------------


                                      2009     2008
                                      ----     ----
Cash provided by (used in):

Loss for the year                   (3,473) (2,321)
Items not involving cash:
  Amortization of capital assets        98       64
  Amortization of intangibles            -        3
  Deferred lease credit                 (8)       -
  Stock-based compensation             160        -
  Foreign exchange loss (gain)         (42)     150
                                       ---      ---
                                    (3,265)  (2,104)
Change in non-cash
 working capital                       917      486
                                      
'/>"/>
SOURCE Helix BioPharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
2. J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory
3. Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA
4. Helix BioPharma Corp. Announces Fiscal 2009 Results
5. Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
6. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
7. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
8. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
9. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
10. Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
11. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 AARP Foundation today announced it has ... adults suffering from the severe cold weather that has ... are committed to helping those in need; so to ... will match dollar-for-dollar contributions up to $250,000, which could ... will be administered through AARP Foundation. ...
(Date:1/15/2014)... Texas , Jan. 15, 2014  Humberto C. ... Dermatology Achievement Award" from the Journal of Drugs ... Aesthetic & Clinical Conference (ODAC). The event is January 17-20, ... Florida . The ODAC ... on the practice of dermatology for clinical and aesthetic ...
(Date:1/15/2014)... -- MultiCell Technologies, Inc. (OTC Bulletin Board: ... concerning composition of matter, biological targets, mechanism of action, ... This patent application describes a novel ... (VSRNAs) which interfere with the basic homeostatic cellular processes ... than 10 bps, yet are surprisingly capable in their ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
... (NASDAQ: PRXL ) announced today that it will ... FL.  James Winschel, Sr. Vice President and Chief Financial Officer ... on Tuesday, March 13, 2012. A live webcast ... section of PAREXEL,s website at www.PAREXEL.com in ...
... Angeion Corporation (NASDAQ: ANGN ) today announced that ... Board of Directors, effective March 1, 2012. ... Choice in Health Care at the Altarum Institute. She also ... School of Nursing at Indiana University/Purdue University at Indianapolis and ...
Cached Medicine Technology:PAREXEL International to Present at Barclays Capital Healthcare Conference 2Wendy D. Lynch, Ph.D., Joins Angeion's Board of Directors 2Wendy D. Lynch, Ph.D., Joins Angeion's Board of Directors 3Wendy D. Lynch, Ph.D., Joins Angeion's Board of Directors 4
(Date:4/14/2014)... In a UT Dallas study involving serious youth offenders, the ... for the next seven years: "How long do you think ... the future encourages offending over time., Author Dr. Alex Piquero ... long life ahead of them offend at very high rates ... going to die much later in life offend much less., ...
(Date:4/14/2014)... SAN FRANCISCO, Calif.--True North Therapeutics, Inc., announced today ... prevents the destruction of human red blood cells ... type of autoimmune hemolytic anemia (AIHA). The article ... C1s, prevents complement activation induced by cold agglutinin ... journal Blood earlier this month. TNT003 ...
(Date:4/14/2014)... world, many people live and work in dim and ... And as the global population continues to rise and ... spread. , To alleviate the problem, Egyptian researchers ... onto narrow streets and alleyways. The panel is mounted ... angle, where it spreads sunlight onto the street below. ...
(Date:4/14/2014)... professor of chemical engineering at Virginia Tech , ... analyze living cells. The long-term goal is to gain ... In his lab , Lu and his students ... events inside cells. These devices promote high sensitivity and ... cells. , Based on their record of achievements, the ...
(Date:4/14/2014)... Australia. Drug discovery company Proteomics International has completed ... companion diagnostic (CDx) test with the validation of ... team authenticated the panel of biomarkers after taking ... biomarkers were validated at high stringency using the ... spectrometry data was then cross-validated using immunoassays in ...
Breaking Medicine News(10 mins):Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Ex vivo efficacy of C1s antibody as Complement inhibitor in cold agglutinin disease 2Health News:Let the sun shine in: Redirecting sunlight to urban alleyways 2Health News:Efficient analysis of small quantity of cells improves chances to understand disease 2
... (HealthDay News) -- The total economic cost of overweight and obesity ... cost in Canada is about $30 billion a year, a new ... States and Canada is the result of: increased need for medical ... of death ($49 billion); loss of productivity due to disability of ...
... whether interstitial brachytherapy has advantages compared to other therapy options ... provide proof in this respect. This is the result of ... in Health Care (IQWiG) on 11 January 2011. In this ... research already completed in 2007. However, it was shown that ...
... January 2011: With its spotlight theme of ,Controversial ... Society of Cardiology (ESC) Congress promises lively discussions and ... as the world,s premier cardiovascular conference and regularly attracts ... through its doors. It will be held this ...
... (MDCT) provides an efficient, effective way to analyze wounds from ... and in the March issue of Radiology . ... improve patient care and aid in both military and civilian ... D.O., M.P.H., from the Uniformed Services University in Bethesda, Md. ...
... that closely mirror some of the key properties of red ... of synthetic blood. The new discovery outlined in ... Proceedings of the National Academy of Sciences during ... to more effective treatments for life threatening medical conditions such ...
... , MONDAY, Jan. 10 (HealthDay News) -- The ... how to create a vaccine that can protect people against ... that people who were infected with the H1N1 virus and ... against a wide variety of flu strains. The virus ...
Cached Medicine News:Health News:Cost of Obesity Approaching $300 Billion a Year 2Health News:Benefit of brachytherapy in patients with early-stage prostate cancer is still unclear 2Health News:Benefit of brachytherapy in patients with early-stage prostate cancer is still unclear 3Health News:Benefit of brachytherapy in patients with early-stage prostate cancer is still unclear 4Health News:Countdown to Paris and ESC Congress 2011 2Health News:Countdown to Paris and ESC Congress 2011 3Health News:CT helps identify bullet trajectories 2Health News:UNC researchers inch closer to unlocking potential of synthetic blood 2Health News:UNC researchers inch closer to unlocking potential of synthetic blood 3Health News:People Who Recovered From H1N1 Offer Clues to Better Vaccine 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: